文章基本信息
- 标题：Cellular and Humoral Immune Responses in Covid-19 and Immunotherapeutic Approaches
- 本地全文：下载
- 作者：Amal Hasan ; Ebaa Al-Ozairi ; Zahraa Al-Baqsumi 等
- 期刊名称：ImmunoTargets and Therapy
- 电子版ISSN：2253-1556
- 出版年度：2021
- 卷号：10
- 页码：63-85
- DOI：10.2147/ITT.S280706
- 出版社：Dove Medical Press Ltd
- 摘要：Coronavirus disease 2019 (Covid-19), caused by the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can range in severity from asymptomatic to severe/critical disease. SARS-CoV-2 uses angiotensin-converting enzyme 2 to infect cells leading to a strong inflammatory response, which is most profound in patients who progress to severe Covid-19. Recent studies have begun to unravel some of the differences in the innate and adaptive immune response to SARS-CoV-2 in patients with different degrees of disease severity. These studies have attributed the severe form of Covid-19 to a dysfunctional innate immune response, such as a delayed and/or deficient type I interferon response, coupled with an exaggerated and/or a dysfunctional adaptive immunity. Differences in T-cell (including CD4 T-cells, CD8 T-cells, T follicular helper cells, γδ-T-cells, and regulatory T-cells) and B-cell (transitional cells, double-negative 2 cells, antibody-secreting cells) responses have been identified in patients with severe disease compared to mild cases. Moreover, differences in the kinetic/titer of neutralizing antibody responses have been described in severe disease, which may be confounded by antibody-dependent enhancement. Importantly, the presence of preexisting autoantibodies against type I interferon has been described as a major cause of severe/critical disease. Additionally, priorVaccine and multiple vaccine exposure, trained innate immunity, cross-reactive immunity, and serological immune imprinting may all contribute towards disease severity and outcome. Several therapeutic and preventative approaches have been under intense investigations; these include vaccines (three of which have passed Phase 3 clinical trials), therapeutic antibodies, and immunosuppressants. © 2021 Hasan et al.
- 关键词：SARS-CoV-2;autoantibodies;cytokines;immune regulation;inflammation;neutralizing antibodies;type I interferon
